HIGHFDA DRUG

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC...

Presence of particulate matter: a white thread-like structure in the cartridge

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
April 24, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
April 24, 2026
Hazard Level
HIGH
Brands
LIRAGLUTIDE, Lupin Pharmaceuticals, Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
LIRAGLUTIDE, Lupin Pharmaceuticals, Inc.
Model numbers
Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027, WB00103, Expires: Oct. 2027, WC00016, Expires: Dec. 2027 +8 more
UPC codes
70748-346, 70748-346-02, 70748-346-03
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    April 24, 2026

  2. Reported by FDA DRUG

    May 27, 2026

  3. RecallRadar source check

    June 3, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of particulate matter: a white thread-like structure in the cartridge

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Lupin Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for LIRAGLUTIDE recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.. Generic: LIRAGLUTIDE; Brand: LIRAGLUTIDE. Reason: Presence of particulate matter: a white thread-like structure in the cartridge. Classification: Class II. Quantity: 217,621 pen injectors. Distribution: Nationwide within U.S

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lots: a) WB00097
WB00094
WB00088
Expires: Jul. 2027
WB00103
+11 more
UPC Codes
70748-346
70748-346-02
70748-346-03
Affected States
ALL
Report Date
May 27, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE